Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 6/30/2012 | 3/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Market Cap | $465 | $620 | $465 | $325 |
| - Cash | $66 | $107 | $87 | $19 |
| + Debt | $5,027 | $5,027 | $4,944 | $4,769 |
| Enterprise Value | $5,425 | $5,539 | $5,322 | $5,076 |
| Revenue | $876 | $948 | $1,111 | $1,107 |
| % Growth | -7.6% | -14.7% | 0.4% | – |
| Gross Profit | $402 | $453 | $351 | $407 |
| % Margin | 45.9% | 47.8% | 31.5% | 36.8% |
| EBITDA | -$6 | $28 | -$85 | -$211 |
| % Margin | -0.7% | 2.9% | -7.6% | -19.1% |
| Net Income | -$163 | -$132 | -$244 | -$369 |
| % Margin | -18.6% | -13.9% | -21.9% | -33.3% |
| EPS Diluted | -0.011 | -0.01 | -0.02 | -0.02 |
| % Growth | -5% | 50% | 0% | – |
| Operating Cash Flow | -$51 | $17 | -$117 | -$208 |
| Capital Expenditures | -$4 | -$16 | -$7 | -$65 |
| Free Cash Flow | -$54 | $1 | -$124 | -$273 |